Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Xtant Medical Holdings (XTNT) Restructuring Costs (2017 - 2018)

Xtant Medical Holdings (XTNT) has disclosed Restructuring Costs for 2 consecutive years, with $388000.0 as the latest value for Q4 2018.

  • Quarterly Restructuring Costs fell 79.21% to $388000.0 in Q4 2018 from the year-ago period, while the trailing twelve-month figure was $3.0 million through Dec 2018, down 36.72% year-over-year, with the annual reading at $3.0 million for FY2018, 36.54% down from the prior year.
  • Restructuring Costs for Q4 2018 was $388000.0 at Xtant Medical Holdings, down from $614000.0 in the prior quarter.
  • The five-year high for Restructuring Costs was $1.9 million in Q4 2017, with the low at $388000.0 in Q4 2018.